Mexichem Acquires US PVC Producer

Mexichem has acquired Sylvin Technologies, a niche PVC compounds manufacturer,...
Mexichem has acquired Sylvin Technologies, a niche PVC compounds manufacturer, for $39 million on a debt-free and cash-free valuation basis. (c) Mexichem

Mexichem has acquired Sylvin Technologies, a niche PVC compounds manufacturer, for $39 million on a debt-free and cash-free valuation basis.

Located in Lancaster County in the US state of Pennsylvania, Sylvin makes flexible and semi-rigid vinyl and vinyl alloy compounds. Mexichem said Sylvin’s key raw materials of PVC resin, plasticizers and stabilizers should bring synergies to its vinyl operations.

“This transaction continues Mexichem’s strategy of completing bolt-on acquisitions that expand its portfolio of specialty products and applications and give access to new end markets and customers, driving future growth. These products and applications can be further leveraged globally as we expand in other parts of the world,” said Sameer Bharadwaj, president of Mexichem’s compounds business unit.

Sylvin’s total sales for 2017 are expected to reach $29 million. Mexichem will consolidate then new acquisition into its vinyls business as part of its compound unit. The Mexican company’s vinyls group reported sales of $2.2 billion for the year ended Sept. 30, 2017.

Separately, Mexichem has received approval from the Brazilian antitrust authority CADE for the acquisition of Netafim, an Israeli manufacturer of irrigation equipment.

The decision was published in the Brazilian Official Gazette on Jan. 22. Mexichem announced last August that it was to acquire an 80% stake in Netafim from shareholders Permira, Kibbutz Magal and Kibbutz Hatzerim.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.